The lateral division of the bed nucleus of the stria terminalis (BNST), which forms part of the circuitry regulating fear and anxiety, contains a large number of neurons expressing corticotropin releasing factor (CRF), a neuropeptide that has a prominent role in the etiology of fear-and anxiety-related psychopathologies. Stress increases CRF expression within BNST neurons, implicating these cells in stress-and anxiety-related behaviors. These experiments examined the effect of chronically enhanced CRF expression within BNST neurons on conditioned and unconditioned anxiety-related behavior by using a lentiviral vector containing a promoter that targets CRF gene overexpression (OE) to CRFergic cells. We found that BNST CRF-OE did not affect unconditioned anxiety-like responses in the elevated plus maze or basal acoustic startle amplitude. CRF-OE induced before training weakened sustained fear (conditioned anxiety); when induced after conditioning, CRF-OE increased expression of the conditioned emotional memory. Increased BNST CRF expression did not affect plasma corticosterone concentration but did decrease CRFR1 receptor density within the BNST and CRFR2 receptor density within the dorsal portion of the caudal dorsal raphe nucleus. These data raise the possibility that the observed behavioral effects may be mediated by enhanced CRF receptor signaling or compensatory changes in CRF receptor density within these structures. Together, these studies demonstrate that CRF neurons within the lateral BNST modulate conditioned anxiety-like behaviors and also suggest that enhanced CRF expression within these neurons may contribute to inappropriate regulation of emotional memories.
Introduction
The bed nucleus of the stria terminalis (BNST) is a component of the circuitry involved in stress, anxiety and fear, and is particularly important for maintaining long-duration fear responses that resemble anxiety. 1, 2 In rodents, lesioning, inactivation or pharmacological manipulation of the BNST alters anxiety-like behavior in several paradigms, [2] [3] [4] [5] while in human and nonhuman primates, imaging studies have suggested that the BNST is activated by anxiogenic stimuli. [6] [7] [8] [9] The lateral BNST contains a large number of neurons that express the neuropeptide corticotropin releasing factor (CRF [10] [11] [12] ). CRF has been strongly implicated as a regulator of neural circuits that govern autonomic, neuroendocrine and behavioral stress responses. [13] [14] [15] [16] [17] CRF receptor signaling influences several aspects of fear learning and expression. [18] [19] [20] [21] [22] Specifically, extra-hypothalamic CRF overexpression (OE) within the central nervous system increases fear-and anxietyrelated behavior, 14, 23, 24 and chronic CRF hyperactivity has been linked to stress-and fear-related psychopathologies such as post-traumatic stress disorder (PTSD 17, [25] [26] [27] [28] [29] ). The effects of stress on associative emotional learning tend to parallel those produced by CRF receptor signaling. 30 In fact, stressful experience elevates CRF expression within fear-and anxiety-associated structures, including both the dorsolateral and ventrolateral subdivisions of the BNST. [31] [32] [33] [34] This raises the possibility, then, that enhanced CRF expression within these BNST subdivisions modulates conditioned or unconditioned anxiety and possibly contributes to stress-related psychopathology. Therefore, the primary goal of the present studies was to investigate the role of BNST CRF-OE in acquisition and expression of conditioned anxiety (modeled by sustained fear) and in unconditioned anxiety behaviors. Because BNST CRF neurons within the lateral subdivision project to a number of target structures involved in fear modulation [35] [36] [37] including the hypothalamic paraventricular nucleus where the hypothalamic-pituitary-adrenal (HPA) response is initiated, 38 a secondary goal was to determine if BNST CRF-OE would alter plasma corticosterone levels or CRF receptor density in fearand anxiety-related target structures. To accomplish these goals, we used a lentiviral vector (LV-CRF) to chronically overexpress CRF within CRF-expressing BNST neurons. We hypothesized that BNST CRF-OE effects on anxiety and conditioned fear would in some ways resemble those produced by chronic stress.
Materials and methods
Plasmid construction Viral vectors were derived from the HIV-based lentiviral backbones optimized by the laboratory of Dr Didier Trono. 39 The Lenti-CMV-GFP viral plasmid was the 'pCM02' vector, which was a generous gift from the laboratory of Dr Joshy Jacob. PCM02 was created by inserting the 1.4-kb BamHI/XhoI fragment containing GFP-WPRE (woodchuck posttranscriptional regulatory element) from the pHR 0 -CMV-GFP-WPRE plasmid 40 into BamHI/XhoI sites of the pHR-GFP-SIN backbone in place of the green fluorescent protein (GFP) fragment. 40 The resulting pCM02 lentiviruspackaging vector contained a cytomegalovirus (CMV) promoter driving GFP expression followed by a WPRE.
The LVCRFp3.0CRF construct was created as previously described. 41 Briefly, a 3.0-kb region upstream of the CRF gene transcription start site containing several key regulatory elements 42 was amplified from mouse BAC clone #129A14 and then ligated to the CRF coding sequence (from a plasmid generously provided by Wylie Vale, Salk Institute). This construct was then inserted into a LV packaging construct, pCMV-GFP-dNhe (the kind gift of Inder Verma, Salk Institute, La Jolla, CA, USA 43 ) in place of the CMV-GFP sequence. Correctly oriented clones were verified with restriction digests. The LVCRFp3.0CRF lentivirus-packaging vector thus contains a CRF neuron-specific promoter driving CRF gene expression (see Figure 1) .
Preparation of lentiviral stocks
Virus was generated by transient co-transfection of the expression plasmid (25 mg), VSV-G pseudotyping construct (12.5 mg) and the packaging construct pCMVDR8.92 (18.8 mg) into a 150-mm plate of 90% confluent 293T cells as previously described. 39, 44, 45 Medium was collected 48 and 72 h post transfection, cleared of debris by low-speed centrifugation and filtered through 0.45 mm filters. High-titer stocks were prepared by ultracentrifugation in an Optima L-100XP ultracentrifuge (Beckman Coulter, Brea, CA, USA). The initial ultracentrifugation was for 2 h at 28 000 r.p.m. (Ti-45 rotor), and the second centrifugation was at 28 000 r.p.m. for an additional 2 h using a SW41 rotor. Viral pellet was resuspended in 1% bovine serum albumin/phosphate-buffered saline, and stored at À80 1C. Viral titers were determined by infection of 293T cells. Titers of stocks used in these studies were all about 2 Â 10 9 infectious particles per ml.
Animals and housing
Male Sprague-Dawley rats (Charles River, Raleigh, NC, USA), weighing between 275 and 350 g at the time of surgery and housed in groups of four in 45 Â 20 Â 24 cm (depth Â width Â height) polycarbonate cages, were maintained on a 12-h light/dark cycle (lights on at 0800 h) with food and water available ad libitum. A total of 100 animals were used in these experiments. All procedures were conducted in accordance with US Department of Agriculture, Emory University, and National Institutes of Health standards for the care and use of laboratory animals.
Surgical procedures
Before surgery, rats were anesthetized with 75 mg kg À1 (intraperitoneally) ketamine (Bioniche Pharma, Galway, Ireland) and 0.5 mg kg À1 (intraperitoneally) Dexdomitor (Orion Pharma, Espoo, Finland) and also given an analgesic dose of 1.0 mg kg À1 (subcutaneously) meloxicam (Boehringer Ingelheim, Ingelheim am Rhein, Germany) to reduce post-operative discomfort. Once unresponsive to tail pinch, rats were placed in a Kopf Instruments (Tujunga, CA, USA) stereotaxic frame with the nose bar set to À3.8 mm (flat-skull position). A 5-ml Hamilton microsyringe with a 26-gauge needle was sterilized with 100% ethanol, coated with 1% bovine serum albumin, loaded with virus, and then lowered into the BNST (201 coronal angle-to avoid the lateral ventricle, 0.3 mm caudal, 6.3 mm ventral, and 3.8 mm lateral to bregma). Each animal was infused bilaterally with 2 ml of virus at a rate of 0.2 ml min À1 (Ultramicropump3/Micro4 Controller; World Precision Instruments, Sarasota, FL, USA). The needle was left in place for 10 min after the injection and then slowly removed over a 2-min period. The skin was closed using a 5-0 Nylon suture (Ethilon, Johnson & Johnson, Piscataway, NJ, USA). After surgery was complete, 0.5 mg kg À1 Antisedan (Orion Pharma) was given to reverse the anesthetic effects. Animals were given 14 days for recovery and to allow sufficient time for viral infection and induction of CRF or GFP expression. These lentiviruses typically cause CRF or GFP expression for the life of the animal.
Equipment
Startle apparatus. Rats were trained and tested in four identical 8 Â 15 Â 15 cm Plexiglas and wire mesh cages that were each suspended between compression springs within a steel frame located within a customdesigned sound-attenuating chamber. The floor of each cage consisted of four 6.0 mm diameter stainless steel bars spaced 18 mm apart. Startle responses were evoked by 50 ms 95 dB white-noise bursts (5 ms risedecay time, 0-22 kHz) generated by a Macintosh G3 computer sound file, amplified by a Radio Shack amplifier (Model MPA-200; Tandy; Fort Worth, TX, USA), and delivered through Radio Shack Supertweeter speakers located 4 cm in front of each cage. Background noise (60 dB wideband) was produced by an ACO Pacific white-noise generator (Model 3024; Belmont, CA, USA), and the conditioned stimulus (CS) was a 70-dB, 60-Hz clicker stimulus delivered through the same speakers as those used to provide startle and background noise. Sound level measurements were made with a Brü el & Kjaer (Naerum, Denmark) model 2235 sound-level meter (A scale; random input) with the microphone (Type 4176) located 10 cm from the center of the speaker, which approximates the distance of the rat's ear from the speaker during testing. The unconditioned stimulus was a 0.5-s 0.4-mA scrambled shock delivered through the floor bars. Shock intensity was measured with a 1-kO resistor across a differential channel of an oscilloscope in series with a 100-kO resistor connected between adjacent floor bars within each cage. Current was defined as the root-mean-square voltage across the 1-kO resistor where mA = 0.707 Â 0.5 Â peak-to-peak voltage. Shocks were produced by LeHigh Valley shock generators (SGS 004; Beltsville, MD, USA).
Startle response and shock reactivity amplitudes were quantified using an accelerometer (model U321AO2; PCB Piezotronics, Depew, NY, USA) affixed to the bottom of each cage. Cage movement (for example, produced by the rats' startle response or reaction to shock) resulted in displacement of the accelerometer, which in turn produced a voltage output proportional to the velocity of cage movement. This output was amplified (model 483B21; PCB Piezotronics) and digitized on a scale of 0-9.98 units by an InstruNET device (model 100B; GW Instruments, Somerville, MA, USA) interfaced to a Macintosh G3 computer. Startle amplitude was defined as the maximal peak-to-peak voltage that occurred during the first 200 ms after onset of the startle-eliciting whitenoise burst. Similarly, shock reactivity amplitude was defined as the maximal peak-to-peak voltage that occurred during the 500-ms foot-shock presentation. The presentation and sequencing of all stimuli were under the control of the Macintosh G3 computer using custom-designed software (The Experimenter; Glassbeads Inc., Newton, CT, USA). Behavioral procedures Fear conditioning and startle testing. On each of 3 consecutive days, rats received a baseline acoustic startle test in which they were exposed to 30 startleeliciting white-noise bursts (95 dB, 50 ms duration) at an interstimulus interval of 30 s. Based on mean startle amplitude to these stimuli, rats were assigned to different treatment groups (LV-GFP or LV-CRF) such that the average pre-infusion startle amplitude of each group was comparable. The next day, rats received a pre-conditioning test consisting of a 5-min acclimation period, followed by 24 presentations of the startle-eliciting noise bursts (interstimulus interval of 30 s). The last eight were given during a 4-min presentation of a 70-dB, 60-Hz clicker stimulus. After this test, rats received three fear conditioning sessions on consecutive days. During each conditioning session, the rats received eight presentations of a variable-duration clicker stimulus (3-, 10-, 20-s, 1-, 2-, 4-, 6-, 8-min), each co-terminating with a 0.4-mA 500-ms foot-shock unconditioned stimulus (intertrial interval = 3 min). Shock reactivity (jump amplitude in response to the first foot shock of each conditioning session) was recorded for each shock presentation throughout the three conditioning sessions. Clicker presentations occurred in order of ascending duration on the first training day, and randomly thereafter. Startle-eliciting noise bursts were also presented during training (one every 30 s). In all, 2 (Experiment 1) or 15-16 (Experiment 2) days later rats received a test identical to that described above (that is, startle measured for 8 min without the clicker and for an additional 4 min in the presence of the clicker). To minimize startle potentiation due to contextual fear conditioning, cages were illuminating by a fluorescent light (150 lux as measured from the middle of the cage) and scented with 30% acetic acid during conditioning, whereas test sessions were conducted in dim red light without any explicit olfactory cue, the floor bars were covered with sandpaper, and two 5-cm chains hung from the test cage ceiling.
Rats in Experiment 1 (8 LV-GFP, 8 LV-CRF) were infused with virus before conditioning (see experimental timeline, Figure 2a ). In Experiment 2, rats were infused with virus 24-48 h after conditioning (see experimental timeline, Figure 3a ). Experiment 2 was conducted in two replications. The results from each were very similar and have been combined for the statistical analyses that follow (combined Ns = 24 LV-GFP, 23 LV-CRF).
For Experiment 1, baseline acoustic startle amplitude (averaged over three test sessions) was expressed as the log of the post-infection amplitude to preinfection amplitude ratio and analyzed using independent samples t-test (see Keene 46 and Miles et al 47 for a discussion of the merit of log transforms for these sorts of ratio scores). The shock reactivity averaged over all three conditioning sessions was also analyzed using an independent samples t-test. Startle amplitude was also analyzed for each conditioning session, using independent samples t-tests. For conditioned fear tests in Experiments 1 and 2, startle amplitude was expressed as the log of the postconditioning amplitude to pre-conditioning amplitude ratio and then analyzed using separate 2 Â 2 factorial ANOVAs for each experiment, with treatment (that is, CRF-OE vs control) as a betweensubjects factor and test phase (before vs during the clicker CS) as a within-subjects factor. A similar 2 Â 2 factorial ANOVA with repeated measures on test phase was used to compare the average startle amplitude before CS presentation with the startle response evoked within 3 s of CS onset. As suggested elsewhere for analysis of ratio measures and in keeping with our previously published analyses of similar data, 46,47 log transforms were used for this analysis as well.
EPM/DW. Twenty-five rats (15 LV-GFP and 10 LV-CRF) were tested for anxiety-like behavior in two separate assays: the EPM and the DW box, both of which have been shown to be sensitive to pharmacological CRF manipulations. 48, 49 All animals were handled for 2 min on each of 4 days before testing. On Effects of BNST CRF overexpression on anxiety KS Sink et al the fifth and sixth days, they were taken to the test room 30 min before test sessions to acclimate to the room. Each rat was tested once for 2 consecutive days on either DW or EPM, in counterbalanced manner. Data were first analyzed to determine if order of testing impacted results. No order effects were found, so data from both test days were analyzed together for each assay.
EPM testing was conducted in a room illuminated by a single red light bulb over the center of the maze. Each rat was placed on the maze for 5 min. The apparatus was novel to the subjects at the time of testing, and each subject was tested only once. Between subjects, the maze was wiped with Quatricide (Pharmacal, Naugatuck, CT, USA). All testing was conducted within 2 h after the beginning of the dark cycle (that is between 1900 and 2100 h). Sessions were video recorded, and scored for (1) (4) number of entries into the closed arms, by an observer blind to the animal's treatment. A rat was considered to have entered or spent time in an arm only when all four paws were in the respective arm. According to the ethopharmacological factor analysis of Cruz et al., 50 percent of total time spent in open arms, percent of total entries into open arms, and number of entries into closed arms were analyzed using independent samples t-tests.
DW testing was conducted under ambient room lighting between 1400 and 1800 h. To begin the trial, the white PVC tube was placed in front of the rat while the experimenter gently guided the animal into the tube. The tube was then placed into a corner of the field, with the open end of the tube facing away from the corner along one of the walls. Each video-recorded trial lasted 10 min. During scoring, a piece of acetate film marked with perpendicular lines divided the arena into 54 10-cm squares for the purposes of estimating locomotor activity. An experimenter blind to the treatment condition scored the videos for (1) the total number of exits from the PVC tube into the arena, (2) the total time spent outside of the tube and (3) the total number of line crossings during the trial. A rat was considered to have crossed a line if both of its front feet crossed over the line, and was considered to be outside of the tube if two third of its body was outside the tube.
Plasma corticosterone analysis
Twelve rats (6 LV-GFP and 6 LV-CRF) from Experiment 2 were subjected to 30 min of intermittent footshock stress (0.4 mA, 1 s duration, average period: 1 min) and then killed 10 min after the end of the session. An additional 12 animals (6 LV-GFP and 6 LV-CRF) were killed 2 weeks after virus infusion without experiencing any stress procedures or behavioral testing. Blood was collected via cardiac puncture into EDTA-coated tubes, and centrifuge-separated plasma was frozen at À80 1C until analysis. Because circulating corticosterone levels vary diurnally, all blood collections were performed between 1200 and 1430 h. Corticosterone was measured using a Coat-aCount Radioimmunoassay kit (Siemens Healthcare Diagnostics, Deerfield, IL, USA). All samples were run in triplicate together in a single assay on a Wizard2 Gamma Counter (Perkin-Elmer, Waltham, MA, USA). Two levels of a commercial quality control serum were run along with each assay. Factorial ANOVA with two stress levels (baseline or foot-shock stressed) and two treatment conditions (BNST CRF-OE or control) was used to analyze plasma corticosterone levels.
In-situ hybridization Rats were euthanized by administration of isoflurane and brains rapidly extracted, frozen on dry ice and stored at À80 1C. In some cases, animals were perfused before tissue extraction. In all, 20-mm thick sections from throughout the entire rostro-caudal extent of the BNST were cut at À20 1C and mounted onto gelatincoated slides. In-situ hybridization was performed as previously described. 45, 51 Briefly, , NEN, Boston, MA, USA) labeled riboprobes were prepared from linearized clones using T3 polymerase at high specific activity by only using radioactive UTP in the polymerase reaction, with B20-40% incorporation. Following preparation of full-length antisense RNA strands, the RNA was base hydrolyzed to average lengths of 50-100 bp and then purified using a sephadex spin column (Illustra ProbeQuant G-50 microcolumn; GE Healthcare, Chalfont St. Giles, UK). In all, 1 Â 10 5 c.p.m. ml À1 of radioactive probe was applied to each slide, which was immediately covered with parafilm to incubate at 52 1C overnight. Slides were stringently washed, placed against Kodak (Rochester, NY, USA) MR autoradiographic film for 1-5 days, and then developed in a Minolta SRX-101A film processor (Wayne, NJ, USA). Autoradiography films were scanned using a high-resolution Epson 3700 flat-bed scanner (Long Beach, CA, USA) at 6000 d.p.i. The signal intensities of brain regions were calculated on the basis of gray values between 0 (brightest) and 255 (darkest) obtained from the luminosity histogram feature of Adobe Photoshop. For each animal, hybridization signal was determined bilaterally by measuring the most intense 540-pixel circular region within each dorsolateral BNST region, as well as a background area with little or no hybridization signal (cortex). The anatomical level of analysis was verified using the rat brain atlas of Paxinos and Watson. 52 An independent measures t-test was performed on bilaterally averaged BNST CRF mRNA levels for all animals included in these experiments to determine if the LV-CRF virus significantly increased BNST CRF mRNA expression. Individual LV-CRF-treated rats were excluded from behavioral analysis if their average CRF mRNA level for both hemispheres was not greater than the control group mean.
CRFR1 and CRFR2 receptor binding autoradiography CRFR1 receptor binding autoradiography was performed as previously described 53 ,54 on fresh frozen brain tissue obtained from 12 (6 LV-GFP and 6 LV-CRF) behaviorally naive animals killed 2 weeks after virus infusion (same animals from which blood samples were obtained for corticosterone analysis). Sections containing basolateral amygdala, BNST, dorsal raphe nucleus, locus coeruleus, parabrachial nucleus, hypothalamic paraventricular nucleus, and ventrolateral periaqueductal gray were cut at À20 1C and mounted onto four serial slide sets. These regions were chosen for their high CRF receptor density, their reception of BNST CRF projections, and/or their role in fear/anxiety behavior. [36] [37] [38] [55] [56] [57] For each region, two slide sets were thawed at room temperature until dry, fixed in 0.1% paraformaldehyde-phosphate-buffered saline (pH 7.4) for 2 min, then washed in a preincubation medium (19 1C 2 Â 10 min) consisting of 50 mM Tris-HCl, pH 7.4. The slide-mounted sections were then incubated at 19 1C for 2 h in a tracer buffer (50 mM Tris base, mM MgCl, 0.1% bovine serum albumin) containing 0.2 nM 125 I-Sauvagine (PerkinElmer). Because Sauvagine is a non-selective CRF agonist, cold selective CRF receptor antagonists were added to the tracer buffer to confer receptor binding specificity. To achieve selective CRFR1 binding, 500 nM of the CRFR2 antagonist Astressin-2B (SigmaAldrich, St Louis, MO, USA) was added to the tracer buffer during incubation, and selective CRFR2 binding was achieved by adding 500 nM of the CRFR1 antagonist CP-154,526 (a generous gift from Michael J Owens, Emory University). Following incubation, slides were washed in 50 mM Tris base with 10 mM MgCl (pH 7.4) 4 Â 5 min plus 30 min with slow stirring. Finally, slides were briefly dipped in deionized water, dried and apposed to Kodak MR autoradiographic film along with 125 I-microscale standards (GE Healthcare) for 85 h. Autoradiograms were quantified using previously published procedures. 53, 54, 58 Briefly, films and microscale standards were digitized (MTI CCD72 camera, Michigan City, IN, USA) and quantified using AIS 6.0 (MCID, Linton, Cambridge, UK). For each region of interest, unilateral optical density measurements were taken and averaged across three adjacent sections. A standard curve created using eight 125 I standard concentrations was used to convert optical density to decays per minute per mg of tissue (d.p.m. mg ). To control for non-specific background binding, optical density from an area of low binding adjacent to the region of interest was subtracted before statistical analysis. For each region, the corrected d.p.m. mg À1 was analyzed using Mann-Whitney U-tests.
Results

Verification of CRF constitutive OE within BNST
We achieved CRF-OE within the BNST using a LV containing a 3.0-kb promoter region upstream of the CRF gene transcription start site driving CRF gene expression (Figure 1a) . This promoter has previously been shown to confer restricted CRF cell-specific expression in transgenic animals, 59 and this same LVCRFp3.0CRF lentivirus construct has produced robust CRF-OE within the central nucleus of the amygdala and the hypothalamic paraventricular nucleus. 41 LVCRFp3.0CRF-induced CRF-OE within the BNST was assessed using in-situ hybridization. CRF mRNA expression levels were significantly higher in CRF-OE rats compared with controls (optical brightness compared with background, GFP: 21.8 vs CRF: 44.8; t = 5.2, P < 0.001; Figure 1b , and see Figure 1c for representative sections from LV-CRF and LV-GFP animals). Previous work from our group with a similar viral vector has demonstrated virus-induced CRF peptide expression in vivo.
14 CRF-OE induced before conditioning impairs fear acquisition There were no significant differences between BNST CRF-OE and control animals in baseline acoustic startle response (t = 0.06, P = 0.95), This suggests that CRF-OE in and of itself was not anxiogenic. During the first conditioning session, however, CRF-OE animals exhibited diminished startle sensitization as measured by the average acoustic startle amplitude after the first foot shock of the session (t = 2.34 P = 0.047; Figure 2b) . However, by the second and third conditioning sessions, both groups were exhibiting similar startle levels (session 2: t = 2.34, P = 0.79; session 3: t = 1.038, P = 0.32). BNST CRF-OE rats also exhibited a markedly blunted shock reactivity in response to the initial foot shock of the conditioning sessions (Figure 2c ; t = 2.65, P = 0.02).
In harmony with these acquisition data, which might suggest weaker conditioning in the CRF-OE group, fear-potentiated startle during the sustained CS was rapidly attenuated in BNST CRF-OE animals. While both treatment groups exhibited similarly enhanced fear during the initial 15 s of CS presentation (potentiation of startle vs pre-conditioning test: LV-GFP, 0.36 ± 0.13 vs LV-CRF, 0.24 ± 0.15; CS effect: F 1,14 = 7.86, P = 0.032; treatment effect: F 1,14 = 0.091, P = 0.74; treatment Â CS interaction: F 1,14 = 0.72, P = 0.41); over the duration of the entire 4 min CS, the average startle potentiation in CRF-OE rats rapidly declined to near pre-CS levels while startle in controls remained elevated (average startle potentiation vs pre-conditioning test: LV-GFP, 0.31 ± 0.07 vs LV-CRF, À0.12 ± 0.08; treatment effect: F 1,14 = 5.39, P = 0.036; treatment Â CS interaction: F 1,14 = 10.41, P = 0.006; Figure 2d ). Pre-CS startle levels after conditioning were comparable to pre-conditioning levels in both groups (LV-GFP, 0.03±0.09 vs LV-CRF, 0.08±0.1). Thus, there was no evidence in either group of context conditioning. Together, data from the conditioning and test sessions suggest that OE of CRF within the BNST before training impairs acquisition of the associative fear memory.
OE of CRF after conditioning enhances conditioned fear expression
To determine whether OE of CRF would also affect retention/expression of BNST-dependent conditioned sustained fear, we performed another experiment in which animals were fear conditioned, infused with virus, then tested 15-16 days later. During the test session (Figure 3b) , both treatment groups exhibited enhanced fear compared with pre-CS levels during the initial 3 s of the clicker CS (LV-GFP, 0.35 ± 0.13 vs LV-CRF, 0.50±0.12; CS effect: F 1,45 = 13.78, P = 0.001; treatment effect: F 1,45 = 0.49, P = 0.49; treatment Â CS interaction: F 1,45 = 0.82, P = 0.37). However, over the entire 4-min CS duration, GFP-infected animals' startle response returned to baseline, while fear-potentiated startle in CRF-OE rats remained elevated. Factorial ANOVA revealed a significant CS effect (F 1,45 = 4.85, P = 0.03) and a significant interaction between treatment and CS (F 1,45 = 5.14, P = 0.03). As in Experiment 1, BNST CRF-OE and control animals had similarly low levels of startle before CS onset, demonstrating minimal context conditioning (LV-GFP, 0.11 ± 0.05 vs LV-CRF, 0.10 ± 0.06). These data suggest that OE of CRF within the BNST following training enhances fear memory retention or later expression of conditioned fear to a sustained CS.
BNST CRF-OE does not affect unconditioned anxiety Consistent with the lack of a CRF-OE effect on baseline startle amplitude before conditioning or in the absence of the CS during testing (see Figures 2b, d  and 3b ), BNST CRF-OE did not affect unconditioned anxiety measures in the EPM or DW tests (Figure 4) . On the EPM, BNST CRF-OE animals exhibited a similar percentage of entries into open arms (t = 0.02, P = 0.99), percentage of time spent on open arms (t = 0.72, P = 0.48) and number of closed arm entries (t = 1.38, P = 0.18) compared with controls. Similarly, in the DW test there were no differences between groups in the number of withdrawal tube exits (t = 0.15, P = 0.88) the duration of time spent outside of the tube (t = 0.83, P = 0.42), or the total number of line crossings in the arena (t = 0.67, P = 0.51). These results imply that BNST CRF-OE did not affect unconditioned anxiety.
BNST CRF-OE does not affect HPA axis activity Because BNST CRF neurons project to the hypothalamic paraventricular nucleus where HPA axis responses are initiated, we examined whether continuous BNST CRF-OE affects plasma corticosterone levels under basal (low stress) or stressful conditions. As expected, animals that were subjected to 30 min foot-shock stress before blood collection had significantly higher plasma corticosterone levels compared with unstressed rats (stress effect: F 1,20 = 79.9, P < 0.001); however, there were no significant differences between LV-CRF and LV-GFP-treated animals under either basal BNST CRF-OE alters CRF receptor densities within BNST and DRN CRFR1 and CRFR2 receptor densities for selected regions of interest are summarized in Table 1 . MannWhitney U-tests revealed that BNST CRF-OE reduced CRFR1 binding density within the BNST (P = 0.004) and CRFR2 binding density in the caudal dorsal raphe nucleus (DRN) (P = 0.018). Representative autoradiographs from these regions are shown in Figure 6 .
Discussion
The lateral BNST, which is an important neural node in anxiety circuitry, contains a dense population of CRF-expressing neurons. CRF signaling in the central nervous system has been implicated in the regulation of behavioral and neuroendocrine stress responses, and CRF expression is increased by stress. This study was designed to mimic those stress effects on CRF expression within the BNST in an effort to ascertain how these neurons influence anxiety-related behaviors. We used a lentivirus containing a CRF-specific promoter in order to target CRF-OE to the CRFergic neurons of the BNST. Previous work using this promoter has demonstrated 85-90% gene targeting specificity for CRF-producing cells, 59 suggesting that the findings from the present experiments are largely the result of CRF overproduction within CRFergic cells of the BNST. We found that BNST CRF-OE did not affect baseline acoustic startle response or unconditioned anxiety behavior in the EPM or DW tests. However, BNST CRF-OE impaired sustained startle potentiation (modeling conditioned anxiety) when induced before training but enhanced sustained startle potentiation when induced after training. These surprising paradoxical effects suggest that BNST CRF may potentially influence conditioned anxiety through separate, dissociable mechanisms.
When rats were infected with LV-CRF 2 weeks before conditioning, they exhibited blunted startle sensitization during the first day of conditioning, decreased reactivity to the initial foot shock of the conditioning sessions, and rapidly attenuated fearpotentiated startle in response to the sustained CS during testing 2 days later. These results, which are similar to those observed in animals overexpressing CRF in the forebrain 60 or central nucleus of the amygdala 61 before training, suggest that BNST CRF-OE induced associative fear learning deficits, possibly due to reduced sensitivity to the foot-shock unconditioned stimulus or unspecified learning impairments.
In contrast to the impairment of fear conditioning produced by BNST CRF-OE before training, OE of CRF within BNST following conditioning significantly increased fear-potentiated startle throughout the 4-min CS in a test session conducted 15-16 days after conditioning (Figure 3 ). This finding suggests that BNST CRF-OE enhanced expression of the fear memory, in line with studies showing that intracranially administered CRF enhances associative fear. [62] [63] [64] Stress can also strengthen emotional memories in animals as well as in people, [65] [66] [67] and in the extreme can lead to fear-related psychopathology such as PTSD. Considering that BNST CRF neurons are stress sensitive, [31] [32] [33] [34] overactivation of these CRF neurons may represent a mechanism by which stress strengthens expression of associative fear memories. Abbreviations: CRF, corticotropin releasing factor; GFP, green fluorescent protein; LV, lentiviral vector. *P < 0.01. BNST CRF-OE appeared to specifically influence associative anxiety-like responses, as baseline startle amplitude and unconditioned anxiety-related behavior on the EPM were not affected. These results align with a recently published study reporting that BNST CRF-OE in mice produced no significant effects on anxiety-like behavior in EPM, open field or dark-light transfer tests. 23 However, some studies have shown that CRF-OE transgenic mice exhibit an anxious phenotype in tests of unconditioned anxiety. 24, 68 This difference between site-specific BNST CRF-OE and whole brain CRF-OE may indicate that CRF neurons external to the BNST (that is, amygdala, hippocampus or paraventricular hypothalamus) regulate unconditioned anxiety. Indeed, we have found previously that CRF-OE targeted to the central nucleus of the amygdala did enhance basal acoustic startle 14 and anxiety-like behavior in the EPM and DW test, 59 suggesting that central nucleus of the amygdala CRF neurons may at least partially mediate the anxious phenotype of some CRF-OE transgenic animals.
There is also a considerable body of literature showing that exogenously administered CRF enhances anxiety in a number of behavioral paradigms including unconditioned acoustic startle, 22,69-71 and approach-avoidance conflict tests. 72, 73 Although behavioral results from site-specific CRF-OE and exogenously administered CRF (locally or ICV) do share some similarities, it must be noted that these procedures are fundamentally different in that CRF released by infected BNST neurons acts not only locally but may activate receptors in more distal structures targeted by these neurons. Furthermore, chronic CRF-OE may induce compensatory changes in CRF receptor sensitivity or even in non-CRFergic signaling systems. Thus, any attempt to directly compare results obtained by pharmacological CRF administration with studies of targeted CRF gene OE should consider these differences. In contrast to pharmacological studies, we believe that genetically driven enhancement of CRF within CRFergic neurons most closely mimics a state of physiologically enhanced CRF activity, which cannot be modeled as well by pharmacological approaches.
Although the lateral BNST exerts a significant influence on HPA axis activity, 74, 75 OE of CRF within this region did not produce differences in basal or stress-induced plasma corticosterone levels ( Figure  5 ). These findings are consistent with previous data which showed that BNST CRF-OE in mice had no effect on plasma corticosterone under either basal conditions or following acute restraint stress. 23 The similarity of corticosterone data from these two studies argues that CRF from BNST neurons does not have a significant role in HPA regulation, at least under the conditions tested. Also, the failure of BNST-OE to influence corticosterone levels in this experiment might imply that the CRF-OE-induced changes in sustained fear-potentiated startle observed in Experiments 1 and 2 are not the result of CRF-OE-induced alterations in HPA activity. Such a conclusion is not without precedent, in that prior studies have also shown a dissociation of fear behavior and neuroendocrine response under some conditions. [76] [77] [78] We also examined whether enhanced BNST CRF expression induces compensatory changes in CRF receptor density within target structures associated with fear and anxiety. It was found that CRF-OE within the BNST produced lower CRFR1 density within the BNST, and decreased CRFR2 density in the dorsal portion of the caudal DRN. Because CRFR1 and CRFR2 receptors are known to internalize in response to CRF binding, [79] [80] [81] [82] this could suggest that CRF receptors within the BNST and DRN were downregulated as a compensatory response to elevated localized concentrations of CRF peptide. The lower density of CRFR1 receptors within BNST matches findings from a previous study showing that BNST CRF-OE lowered BNST CRFR1 mRNA expression in mice, 23 and aligns with previous studies implicating CRFR1 receptors as actuators of stressinduced anxiety 83 and CRF-enhanced startle. 22, 84 These data suggest that chronically enhanced BNST CRF expression may modulate fear and anxiety in part by altering CRF signaling processes locally within the BNST. CRFR2 downregulation within the caudal DRN suggests BNST CRF-OE causes higher CRF peptide concentrations in this region as well. CRF within the DRN has an important role in stress-induced regulation of serotonin, [85] [86] [87] [88] a critical modulator of fear-and anxiety-related behaviors; 89, 90 and DRN administration of CRF increases fear-like freezing behavior. 91 Given that CRFR2 receptor activation also influences defensive behavior including startle, 20, 84 regulation of DRN serotonergic neurotransmission by BNST CRF neuronal efferents is an intriguing possibility that deserves attention, as this may be a potential mechanism modulating fear-and anxiety-related behaviors. Further studies will be necessary to determine whether these hypothetical mechanisms actually contribute to anxiety-related behavioral alterations such as those produced by BNST CRF-OE in the present experiments.
In conclusion, these studies demonstrate that CRF neurons of the BNST are involved in the modulation of sustained fear-potentiated startle (modeling conditioned anxiety), but not unconditioned anxiety behaviors. As sustained startle potentiation has previously been found in both rats and humans to be especially sensitive to benzodiazepine and chronic SSRI administration, and to be selectively exaggerated in PTSD and panic disorder patients, 1 CRF-OE in the BNST may mimic at least some aspects of these disorders (which in the case of PTSD includes elevated startle as a diagnostic criterion), and may be a useful tool for exploring their neural substrates and for screening novel therapeutic agents.
CRF receptor binding autoradiography showing lower receptor density within the BNST and the DRN suggests that these behavioral effects may involve CRF receptor signaling within these structures. However, HPA axis activation does not appear to have a significant role in these processes. Future work should focus on how these BNST CRF neurons influence signaling in target structures. In light of the associations between CRF signal perturbation and stressassociated fear and anxiety disorders, [25] [26] [27] [28] [29] these findings implicate BNST CRF neurons as important members of the neural network that governs not only adaptive associative fear but also the development of fearrelated psychopathologies such as PTSD.
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